A study by Usuda et al. suggested that klotho provides a new biomarker for good outcome in patients with large cell neuroendocrine carcinoma of the lung, especially among patients without lymph node metastasis or lymphangio invasion [18]. The gene discussed is KL; the disease is metastatic malignant neoplasm in the lymph nodes.